Recruiting Study of GV20-0251 in Participants With Solid Tumor Malignancies NCT07070518 Conditions Adenocarcinoma, Adult Refractory Cancer, Bronchial Neoplasms, +44 more Locations Beijing Cancer Hospital — Beijing, Beijing Municipality, China Cancer Hospital, Chinese Academy of Medical Sciences — Beijing, Beijing Municipality, China Shanghai Pulmonary Hospital — Shanghai, Shanghai Municipality, China View Trial Details
Recruiting A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies NCT05669430 Conditions Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +34 more Locations The Angeles Clinic and Research Institute — Los Angeles, California, United States HealthONE Clinic Services Oncology - Hematology, LLC d/b/a Sarah Cannon Research Institute at HealthONE — Denver, Colorado, United States Yale University — New Haven, Connecticut, United States Florida Cancer Specialists & Research Institute, LLC — Fort Myers, Florida, United States View all 13 locations View more locations Show fewer locations Loading locations... View Trial Details
